Alzheimer Disease and Dementia

Increases in [18F]FDDNP Tied to Future Cognitive Decline

Increases in [18F]FDDNP Tied to Future Cognitive Decline

For individuals without dementia, increases in 2-(1-{6-[(2-fluorine 18-labeled fluoroethyl)methylamino]-2-napthyl}ethylidene) malononitrile ([18F]FDDNP) positron emission tomography (PET) binding in brain regions are associated with future cognitive decline.